Samsara BioCapital as of Sept. 30, 2021
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 46 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Graphite Bio | 19.1 | $122M | 7.4M | 16.39 | |
| Nkarta (NKTX) | 8.9 | $57M | 2.0M | 27.81 | |
| Chinook Therapeutics | 6.8 | $43M | 3.4M | 12.76 | |
| Instil Bio | 6.0 | $38M | 2.1M | 17.88 | |
| Forma Therapeutics Hldgs SHS | 5.7 | $36M | 1.6M | 23.19 | |
| Allakos (ALLK) | 5.7 | $36M | 340k | 105.87 | |
| Sutro Biopharma (STRO) | 5.0 | $32M | 1.7M | 18.89 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 4.0 | $26M | 1.5M | 16.70 | |
| Iveric Bio | 3.7 | $24M | 1.5M | 16.24 | |
| Rain Therapeutics | 3.7 | $24M | 1.6M | 14.96 | |
| Novavax Com New (NVAX) | 3.7 | $23M | 113k | 207.29 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 2.7 | $17M | 753k | 23.01 | |
| Aclaris Therapeutics (ACRS) | 2.2 | $14M | 794k | 18.00 | |
| Springworks Therapeutics (SWTX) | 1.7 | $11M | 170k | 63.44 | |
| Intercept Pharmaceuticals In | 1.5 | $9.5M | 641k | 14.85 | |
| Bolt Biotherapeutics (BOLT) | 1.5 | $9.3M | 738k | 12.65 | |
| Tango Therapeutics (TNGX) | 1.4 | $9.1M | 700k | 12.93 | |
| Janux Therapeutics (JANX) | 1.4 | $8.9M | 412k | 21.63 | |
| Syros Pharmaceuticals | 1.4 | $8.6M | 2.2M | 3.94 | |
| Elevation Oncology (ELEV) | 1.1 | $7.3M | 932k | 7.79 | |
| Aeglea Biotherapeutics | 1.1 | $7.0M | 884k | 7.95 | |
| Decibel Therapeutics | 1.0 | $6.4M | 826k | 7.71 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.0 | $6.1M | 1.1M | 5.48 | |
| Viracta Therapeutics (VIRX) | 0.9 | $5.7M | 711k | 8.02 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.8 | $5.4M | 549k | 9.80 | |
| Equillium (EQ) | 0.8 | $5.0M | 738k | 6.82 | |
| Jiya Acquisition Corp Com Cl A | 0.8 | $4.9M | 507k | 9.75 | |
| Day One Biopharmaceuticals I (DAWN) | 0.8 | $4.8M | 203k | 23.73 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $4.7M | 450k | 10.42 | |
| Rhythm Pharmaceuticals (RYTM) | 0.6 | $3.9M | 300k | 13.06 | |
| Albireo Pharma | 0.5 | $3.1M | 100k | 31.20 | |
| Terns Pharmaceuticals (TERN) | 0.5 | $3.0M | 289k | 10.42 | |
| Bcls Acquisition Corp Com Cl A | 0.5 | $3.0M | 300k | 9.96 | |
| Atreca Cl A Com (BCEL) | 0.4 | $2.5M | 397k | 6.23 | |
| Immunocore Hldgs Ads (IMCR) | 0.4 | $2.4M | 64k | 37.06 | |
| Surrozen | 0.3 | $2.1M | 300k | 7.08 | |
| Allovir (ALVR) | 0.3 | $2.1M | 82k | 25.06 | |
| Odonate Therapeutics Ord | 0.3 | $2.0M | 700k | 2.91 | |
| Kronos Bio (KRON) | 0.3 | $1.6M | 78k | 20.96 | |
| Kala Pharmaceuticals | 0.2 | $1.6M | 601k | 2.62 | |
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $1.6M | 5.8k | 273.01 | |
| Vistagen Therapeutics | 0.2 | $1.3M | 489k | 2.74 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $1.2M | 41k | 29.89 | |
| Ngm Biopharmaceuticals | 0.0 | $287k | 14k | 21.00 | |
| Astria Therapeutics (ATXS) | 0.0 | $221k | 25k | 8.84 | |
| Amarin Corp Spons Adr New (AMRN) | 0.0 | $128k | 25k | 5.12 |
